Study to Evaluate the Safety and Efficacy of ASC42 Tablets in Subjects With Primary Biliary Cholangitis
Clinical trial NCT05190523 · COMPLETED
Trial details
- NCT number
- NCT05190523
- Sponsor
- Gannex Pharma Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-06
- Primary completion
- 2024-03-13
- Enrollment
- 98
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.